JO3130B1 - 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 map kinase inhibitors - Google Patents

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 map kinase inhibitors

Info

Publication number
JO3130B1
JO3130B1 JOP/2012/0283A JOP20120283A JO3130B1 JO 3130 B1 JO3130 B1 JO 3130B1 JO P20120283 A JOP20120283 A JO P20120283A JO 3130 B1 JO3130 B1 JO 3130B1
Authority
JO
Jordan
Prior art keywords
napththalen
anilinopyrimidin
ureas
pyrazolyl
oxy
Prior art date
Application number
JOP/2012/0283A
Other languages
Arabic (ar)
Inventor
Stuart Thomas Onions
Kazuhiro Ito
Rudy Broeckx
Catherine Elisabeth Charron
Walter Filliers
John King-Underwood
Alex Copmans
Alistair Ian Longshaw
Original Assignee
Respivert Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Respivert Ltd filed Critical Respivert Ltd
Application granted granted Critical
Publication of JO3130B1 publication Critical patent/JO3130B1/en

Links

Abstract

There is provided a compound of formula (I) which is an inhibitor of the family of p38 mitogen-activated protein kinase enzymes, and to its use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and COPD.
JOP/2012/0283A 2011-10-03 2012-09-25 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 map kinase inhibitors JO3130B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11183682 2011-10-03
EP12168396 2012-05-16

Publications (1)

Publication Number Publication Date
JO3130B1 true JO3130B1 (en) 2017-09-20

Family

ID=63684623

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2012/0283A JO3130B1 (en) 2011-10-03 2012-09-25 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 map kinase inhibitors

Country Status (1)

Country Link
JO (1) JO3130B1 (en)

Similar Documents

Publication Publication Date Title
MY167798A (en) 1-pyrazolyl-3- (4- ( (2 -anilinopyrimidin- 4 - yl) oxy) napththalen- 1 - yl) ureas as p38 map kinase inhibitors
WO2010067130A8 (en) P38 map kinase inhibitors
EA201171213A1 (en) P38 MAR INHIBITOR KINAZES
PH12014501277A1 (en) Kinase inhibitors
MX362550B (en) Heterocyclic inhibitors of glutaminase.
MX2017004129A (en) 4-(4-(4-phenylureido-naphthalen-1-yl)oxy-pyridin-2-yl)amino-benz oic acid derivative as p38 kinase inhibitor.
IN2014CN00568A (en)
AU2012324803A8 (en) (hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
HRP20130895T1 (en) P38 map kinase inhibitors
UA111382C2 (en) Protein kinase inhibitors
TN2014000128A1 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
MX2013004298A (en) Quinazolin-4 (3h) -one derivatives used as pi3 kinase inhibitors.
MX2015013944A (en) Kinase inhibitor.
AU2012214029A8 (en) Rorgammat inhibitors
MX2015002044A (en) Pyrazolyl-ureas as kinase inhibitors.
PH12014501278A1 (en) Kinase inhibitors
UA104677C2 (en) Urea derivatives and their therapeutic use in the treatment of, inter alia, diseases of the respiratory tract
EA201301130A1 (en) IMIDAZOPIRIDAZINES AS AN INHIBITORS KINASE ACT
JO3063B1 (en) Novel compound and methods for its production
MX2014002395A (en) Novel rock kinase inhibitors.
IN2009DN06586A (en)
JO3130B1 (en) 1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl)ureas as p38 map kinase inhibitors
TN2014000218A1 (en) Kinase inhibitors
TN2011000108A1 (en) 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases